Curis Lifesciences Ltd vs Sai Parenterals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Curis Lifesciences Ltd is ₹ 121 as of 05 May 15:30 . The P/E Ratio of Curis Lifesciences Ltd is 0 as of March 2023 .The P/E Ratio of Sai Parenterals Ltd is 0 as of March 2023 . The Market Cap of Curis Lifesciences Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Sai Parenterals Ltd is ₹ 0 crore as of March 2023 . The Revenue of Curis Lifesciences Ltd is ₹ 9.12 crore as of Jun '24 .The Revenue of Sai Parenterals Ltd is ₹ 0 crore as of Jun '24 . The EBITDA of Curis Lifesciences Ltd is ₹ 2.73 crore as of Jun '24 .The EBITDA of Sai Parenterals Ltd is ₹ 0 crore as of Jun '24 . The Net Profit of Curis Lifesciences Ltd is ₹ 1.2 crore as of Jun '24 .The Net Profit of Sai Parenterals Ltd is ₹ 0 crore as of Jun '24 . The Dividend Payout of Curis Lifesciences Ltd changed from 0 % on March 2022 to 0 % on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Dividend Payout of Sai Parenterals Ltd changed from 0 % on March 2022 to 0 % on March 2025 . This represents a CAGR of 0.0% over 4 years .

About Curis Lifesciences Ltd

Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of 'M/s Loreto Pharmaceutacals', pursuant to a Deed of Partnership dated 2 June, 2010.
Thereafter ' M/s Loreto Pharmaceutacals' was converted from Partnership Firm to a Private Limited Company as 'Curis Lifesciences Private Limited' and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad.
Subsequently, Company was converted into a Public Limited Company and the name of the Company was changed from 'Curis Lifesciences Private Limited' to 'Curis Lifesciences Limited' vide certified incorporated upon the conversion dated August 9, 2024, issued by the Central Processing Centre, Manesar. Company's business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic.

About Sai Parenterals Ltd

Sai Parenteral's Limited was originally incorporated as Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad.
Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to Sai Parenteral's Limited' w.e.f January 17, 2022. Sai Parenteral's is a diversified pharmaceutical formulations company engaged in the business of Branded Generic Formulations and Contract Development and Manufacturing Organization (CDMO) products and services for the domestic and international markets.
Company has developed a comprehensive and diversified portfolio of complex pharmaceutical products, covering both high-value and high-volume categories addressing critical therapeutic needs across the multiple disease areas.

FAQs for the comparison of Curis Lifesciences Ltd and Sai Parenterals Ltd

Which company has a larger market capitalization, Curis Lifesciences Ltd or Sai Parenterals Ltd?

Market cap of Curis Lifesciences Ltd is 97 Cr while Market cap of Sai Parenterals Ltd is 2,161 Cr

What are the key factors driving the stock performance of Curis Lifesciences Ltd and Sai Parenterals Ltd?

The stock performance of Curis Lifesciences Ltd and Sai Parenterals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Curis Lifesciences Ltd and Sai Parenterals Ltd?

As of May 5, 2026, the Curis Lifesciences Ltd stock price is INR ₹121.0. On the other hand, Sai Parenterals Ltd stock price is INR ₹489.35.

How do dividend payouts of Curis Lifesciences Ltd and Sai Parenterals Ltd compare?

To compare the dividend payouts of Curis Lifesciences Ltd and Sai Parenterals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.